i
Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022
-
4 2024
Source: Emerg Infect Dis. 2024; 30(4):775-778 -
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:Given its enhanced genetic stability, novel oral poliovirus vaccine type 2 was deployed for type 2 poliovirus outbreak responses under World Health Organization Emergency Use Listing. We evaluated the safety profile of this vaccine. No safety signals were identified using a multipronged approach of passive and active surveillance.
-
Subjects:
-
Keywords:
-
Pubmed ID:38526214
-
Pubmed Central ID:PMC10977820
-
Document Type:
-
Genre:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
-
File Type: